| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 618934 | 62966 | CIPROFLOXACINO VIR, 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CIPROFLOXACINO VIR, 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 250 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62966/62966_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62966/62966_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2000-03-21 | 1 | 1 | 1 | 2000-03-21 | 2000-03-21 | 0 | 2011-06-08 | View Edit Delete | ||||||||||||
| 698253 | 62966 | CIPROFLOXACINO VIR, 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CIPROFLOXACINO VIR, 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 14 comprimidos | 250 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62966/62966_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62966/62966_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2000-03-21 | 1 | 1 | 1 | 2000-03-21 | 2013-06-04 | 0 | 2013-11-14 | View Edit Delete | ||||||||||||
| 895722 | 63285 | CIPROXINA 2 mg/ml + 10 mg/ml GOTAS OTICAS EN SUSPENSION | CIPROXINA 2 mg/ml + 10 mg/ml GOTAS OTICAS EN SUSPENSION , 1 frasco de 10 ml | 10 mg/ml + 2 mg/ml | 6 | 10 | 26 | 1 frasco de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63285/63285_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63285/63285_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 2000-07-27 | 1 | 1 | 1 | 2000-07-27 | 2000-07-27 | 1 | 2011-11-08 | View Edit Delete | ||||||||||||
| 793802 | 64940 | CIPROXINA SIMPLE 3 mg/ml GOTAS OTICAS EN SOLUCION | CIPROXINA SIMPLE 3 mg/ml GOTAS OTICAS EN SOLUCION , 1 frasco de 5 ml | 3 mg/ml | 41 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64940/64940_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64940/64940_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 2002-07-26 | 1 | 1 | 1 | 2002-07-26 | 2002-07-26 | 1 | 2011-11-08 | View Edit Delete | ||||||||||||
| 701002 | 78331 | CIQORIN 100 MG CAPSULAS BLANDAS EFG | CIQORIN 100 MG CAPSULAS BLANDAS EFG , 30 cápsulas | 100 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78331/78331_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78331/78331_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2013-12-20 | 1 | 1 | 1 | 2013-12-20 | 2014-01-07 | 1 | 2014-08-07 | View Edit Delete | ||||||||||||
| 701004 | 78332 | CIQORIN 25 MG CAPSULAS BLANDAS EFG | CIQORIN 25 MG CAPSULAS BLANDAS EFG , 30 cápsulas | 25 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78332/78332_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78332/78332_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2013-12-20 | 1 | 1 | 1 | 2013-12-20 | 2014-01-07 | 1 | 2014-08-07 | View Edit Delete | ||||||||||||
| 701005 | 78333 | CIQORIN 50 MG CAPSULAS BLANDAS EFG | CIQORIN 50 MG CAPSULAS BLANDAS EFG , 30 cápsulas | 50 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78333/78333_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78333/78333_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2013-12-20 | 1 | 1 | 1 | 2013-12-20 | 2014-01-07 | 1 | 2014-08-07 | View Edit Delete | ||||||||||||
| 683784 | 07392003 | CIRCADIN 2 mg COMPRIMIDOS DE LIBERACION PROLONGADA (30 COMPRIMIDOS) | CIRCADIN 2 mg COMPRIMIDOS DE LIBERACION PROLONGADA (30 COMPRIMIDOS), 30 comprimidos | 2 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07392003/07392003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07392003/07392003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31764 | EXELTIS HEALTHCARE S.L. | 2011-09-12 | 1 | 1 | 1 | 2011-09-12 | 2011-09-12 | 1 | 2013-03-13 | View Edit Delete | ||||||||||||
| 770009 | 07392003IP | CIRCADIN 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA (30 COMPRIMIDOS) | CIRCADIN 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA (30 COMPRIMIDOS), 30 comprimidos | 2 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07392003IP/07392003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07392003IP/07392003IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31764 | MELYFARMA S.L. | 2026-02-27 | 1 | 1 | 1 | 2026-02-28 | 2026-02-27 | 1 | 2026-04-14 | View Edit Delete | ||||||||||||
| 673305 | 73615 | CIRCLET 0,120 mg/0,015 mg CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL | CIRCLET 0,120 mg/0,015 mg CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL 3 dispositivos vaginales | 0,120 mg/24 h + 0,015 mg/24 h | 35 | 3 | 18 | 3 dispositivos vaginales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73615/73615_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73615/73615_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | ORGANON SALUD S.L. | 2012-05-17 | 1 | 1 | 1 | 2012-05-17 | 2012-05-17 | 0 | 2021-06-11 | View Edit Delete | ||||||||||||
| 727649 | 84748 | CIRCULAVEEL COMPRIMIDOS RECUBIERTOS CON PELICULA | CIRCULAVEEL COMPRIMIDOS RECUBIERTOS CON PELICULA 30 comprimidos | 360 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84748/84748_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84748/84748_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10136 | LABORATORIOS HEEL ESPANA SAU | 2019-12-26 | 1 | 1 | 1 | 2019-12-27 | 2019-12-26 | 1 | 2020-06-22 | View Edit Delete | ||||||||||||
| 731342 | 86087 | CISATRACURIO KALCEKS 2 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | CISATRACURIO KALCEKS 2 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 5 ampollas de 5 ml | 2 mg/ml inyectable 5 ml | 1 | 5 | 1 | 5 ampollas de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86087/86087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86087/86087_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31754 | EVER PHARMA THERAPEUTICS SPAIN S.L. | 2021-10-05 | 1 | 1 | 1 | 2021-10-05 | 2021-10-05 | 0 | 2024-02-05 | View Edit Delete | ||||||||||||
| 731343 | 86087 | CISATRACURIO KALCEKS 2 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | CISATRACURIO KALCEKS 2 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 5 ampollas de 10 ml | 2 mg/ml inyectable 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86087/86087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86087/86087_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31754 | EVER PHARMA THERAPEUTICS SPAIN S.L. | 2021-10-05 | 1 | 1 | 1 | 2021-10-05 | 2021-10-05 | 0 | 2022-08-09 | View Edit Delete | ||||||||||||
| 691112 | 76000 | CISATRACURIO NORMON 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | CISATRACURIO NORMON 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG , 5 viales de 5 ml | 2 mg/ml inyectable 5 ml | 45 | 5 | 34 | 5 viales de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76000/76000_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76000/76000_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2012-05-31 | 1 | 1 | 1 | 2012-05-31 | 2012-05-31 | 0 | 2012-11-21 | View Edit Delete | ||||||||||||
| 691114 | 76000 | CISATRACURIO NORMON 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | CISATRACURIO NORMON 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG , 5 viales de 10 ml | 2 mg/ml inyectable 10 ml | 45 | 5 | 34 | 5 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76000/76000_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76000/76000_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2012-05-31 | 1 | 1 | 1 | 2012-05-31 | 2012-05-31 | 0 | 2012-11-21 | View Edit Delete | ||||||||||||
| 691059 | 75987 | CISATRACURIO NORMON 5 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | CISATRACURIO NORMON 5 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial de 30 ml | 5 mg/ml inyectable 30 ml | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75987/75987_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75987/75987_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2012-05-30 | 1 | 1 | 1 | 2012-05-30 | 2012-05-30 | 0 | 2012-11-21 | View Edit Delete | ||||||||||||
| 703889 | 79118 | CISATRACURIO SALA 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | CISATRACURIO SALA 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG , 1 vial de 30 ml | 5 mg/ml inyectable 30 ml | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79118/79118_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79118/79118_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2014-10-20 | 1 | 1 | 1 | 2014-10-20 | 2014-10-20 | 0 | 2017-09-22 | View Edit Delete | ||||||||||||
| 673372 | 72609 | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 10 ml | 1 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72609/72609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72609/72609_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2011-08-11 | 1 | 2012-03-14 | View Edit Delete | ||||||||||||
| 683047 | 72609 | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 50 ml | 1 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72609/72609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72609/72609_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2011-08-11 | 1 | 2012-03-14 | View Edit Delete | ||||||||||||
| 683048 | 72609 | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 100 ml | 1 mg/ml inyectable 100 ml | 45 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72609/72609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72609/72609_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2011-08-11 | 1 | 2012-03-14 | View Edit Delete |
Page 200 of 1036, showing 20 records out of 20704 total, starting on record 3981, ending on 4000